22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- Report blames management for deadly Yunnan tunnel flood
- Companies flock to Shanghai home appliances expo
- Three people perish in Guangdong house fire
- Experts: too early to tell if super El Nino will hit this year
- China recovers $4.95b in medical insurance funds in 2025
- China launches remote sensing satellite
